These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 18300346)

  • 21. [Diagnostic accuracy of 18F-FDG positron emission tomography for evaluation of hepatocellular carcinoma].
    Shin JA; Park JW; An M; Choi JI; Kim SH; Kim SK; Lee WJ; Park SJ; Hong EK; Kim CM
    Korean J Hepatol; 2006 Dec; 12(4):546-52. PubMed ID: 17237633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE.
    Song HJ; Cheng JY; Hu SL; Zhang GY; Fu Y; Zhang YJ
    Clin Radiol; 2015 Feb; 70(2):128-37. PubMed ID: 25459673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma.
    Zhou X; Hu Y; Sun H; Chen R; Huang G; Liu J
    Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3107-3115. PubMed ID: 37147479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma.
    Pant V; Sen IB; Soin AS
    Nucl Med Commun; 2013 Aug; 34(8):749-57. PubMed ID: 23689586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT.
    Kim HO; Kim JS; Shin YM; Ryu JS; Lee YS; Lee SG
    J Nucl Med; 2010 Dec; 51(12):1849-56. PubMed ID: 21098794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidentally found parotid gland lesion in
    Jung JH; Lee YS; Jung YH; Choi SH; Nam SY; Cho HJ; Kwon M
    BMC Surg; 2024 Apr; 24(1):124. PubMed ID: 38658868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (18)F-FDG PET/CT for discrimination between tumor extension and blood thrombus in pancreatic adenocarcinoma associated with portal vein thrombosis.
    Roldán-Valadez E; Ortega-López N; Valdivieso-Cárdenas G; Vega-González I; Herrera-Gómez A
    Rev Esp Med Nucl; 2008; 27(1):40-4. PubMed ID: 18208781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT.
    Talbot JN; Gutman F; Fartoux L; Grange JD; Ganne N; Kerrou K; Grahek D; Montravers F; Poupon R; Rosmorduc O
    Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1285-9. PubMed ID: 16802155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18F-FDG PET-CT in the diagnosis of tumor thrombus: can it be differentiated from benign thrombus?
    Sharma P; Kumar R; Jeph S; Karunanithi S; Naswa N; Gupta A; Malhotra A
    Nucl Med Commun; 2011 Sep; 32(9):782-8. PubMed ID: 21799368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US: a pilot study.
    Song ZZ; Huang M; Jiang TA; Zhao QY; Yao L; Mou Y; Zhao JK; Ao JY; Chen F; Chen Y
    Eur J Radiol; 2010 Aug; 75(2):185-8. PubMed ID: 19464131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor thrombus: ancillary findings on FDG PET/CT in an oncologic population.
    Ravina M; Hess S; Chauhan MS; Jacob MJ; Alavi A
    Clin Nucl Med; 2014 Sep; 39(9):767-71. PubMed ID: 24999677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation.
    Piscaglia F; Gianstefani A; Ravaioli M; Golfieri R; Cappelli A; Giampalma E; Sagrini E; Imbriaco G; Pinna AD; Bolondi L;
    Liver Transpl; 2010 May; 16(5):658-67. PubMed ID: 20440775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18F-fluorodeoxyglucose positron emission tomography/computed tomography enables the detection of recurrent same-site deep vein thrombosis by illuminating recently formed, neutrophil-rich thrombus.
    Hara T; Truelove J; Tawakol A; Wojtkiewicz GR; Hucker WJ; MacNabb MH; Brownell AL; Jokivarsi K; Kessinger CW; Jaff MR; Henke PK; Weissleder R; Jaffer FA
    Circulation; 2014 Sep; 130(13):1044-52. PubMed ID: 25070665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
    Sawicki LM; Grueneisen J; Schaarschmidt BM; Buchbender C; Nagarajah J; Umutlu L; Antoch G; Kinner S
    Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDG-Avid Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma in Contrast-Enhanced FDG PET/CT.
    Nguyen XC; Nguyen DS; Ngo VT; Maurea S
    Asia Ocean J Nucl Med Biol; 2015; 3(1):10-7. PubMed ID: 27408876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficiency of whole-body 18F-FDG PET CT in detecting the cause of rising serum AFP level in post-therapeutic follow-up for HCC patients.
    Ali SA; Amin DH; Abdelkhalek YI
    Jpn J Radiol; 2020 May; 38(5):472-479. PubMed ID: 32078123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective.
    Cheung TT; Ho CL; Lo CM; Chen S; Chan SC; Chok KS; Fung JY; Yan Chan AC; Sharr W; Yau T; Poon RT; Fan ST
    J Nucl Med; 2013 Feb; 54(2):192-200. PubMed ID: 23321459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of 18F-FDG accumulation and arterial enhancement as biomarkers in the assessment of typing, grading and staging of hepatocellular carcinoma using 18F-FDG-PET/CT with integrated dual-phase CT angiography.
    Ferda J; Ferdová E; Baxa J; Kreuzberg B; Daum O; Třeška V; Skalický T
    Anticancer Res; 2015 Apr; 35(4):2241-6. PubMed ID: 25862885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the Outcome of Lung Nodules Missed on 18F-FDG PET/MRI Compared with 18F-FDG PET/CT in Patients with Known Malignancies.
    Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Umutlu L; Antoch G; Heusch P
    J Nucl Med; 2016 Jan; 57(1):15-20. PubMed ID: 26514173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.